Literature DB >> 19682116

Allostatic load and frailty in older adults.

Tara L Gruenewald1, Teresa E Seeman, Arun S Karlamangla, Catherine A Sarkisian.   

Abstract

OBJECTIVES: To examine the association between allostatic load (AL), an index of multisystem physiological dysregulation, and frailty development over a 3-year follow-up in a sample of older adults.
DESIGN: Longitudinal cohort study.
SETTING: Community. PARTICIPANTS: High-functioning men and women aged 70 to 79 at study entry. MEASUREMENTS: Multisystem physiological dysregulation, or AL, was assessed according to 13 biomarkers of cardiovascular, endocrine, immune, and metabolic function. An AL score was computed as the total number of biomarkers for which participant values fell into high-risk biomarker quartiles. Frailty status (not frail, intermediate frail, frail) was determined according to the total number of five indicators of frailty: weight loss, exhaustion, weak grip, slow gait, and low physical activity. The association between level of AL at baseline and frailty status 3 years later was examined using ordinal logistic regression in 803 participants not frail at baseline.
RESULTS: In a multivariable model adjusting for sociodemographic, health, and behavioral characteristics, each 1-unit increase in AL at baseline was associated with a 10% greater likelihood of frailty at the 3-year follow-up (cumulative adjusted odds ratio=1.10, 95% confidence interval=1.03-1.19).
CONCLUSION: These findings support the hypothesis that dysregulation across multiple physiological systems is associated with greater risk of frailty. Greater levels of multisystem physiological dysregulation may serve as a warning sign of frailty development in later life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682116      PMCID: PMC3650612          DOI: 10.1111/j.1532-5415.2009.02389.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  38 in total

1.  Cumulative biological risk and socio-economic differences in mortality: MacArthur studies of successful aging.

Authors:  Teresa E Seeman; Eileen Crimmins; Mei-Hua Huang; Burton Singer; Alexander Bucur; Tara Gruenewald; Lisa F Berkman; David B Reuben
Journal:  Soc Sci Med       Date:  2004-05       Impact factor: 4.634

Review 2.  Preventing frail health.

Authors:  D M Buchner; E H Wagner
Journal:  Clin Geriatr Med       Date:  1992-02       Impact factor: 3.076

3.  An epidemiology of disability among adults in the United States.

Authors:  S Z Nagi
Journal:  Milbank Mem Fund Q Health Soc       Date:  1976

4.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.

Authors:  Jeremy Walston; Mary Ann McBurnie; Anne Newman; Russell P Tracy; Willem J Kop; Calvin H Hirsch; John Gottdiener; Linda P Fried
Journal:  Arch Intern Med       Date:  2002-11-11

5.  A survey for assessing physical activity among older adults.

Authors:  L Dipietro; C J Caspersen; A M Ostfeld; E R Nadel
Journal:  Med Sci Sports Exerc       Date:  1993-05       Impact factor: 5.411

6.  A Guttman health scale for the aged.

Authors:  I Rosow; N Breslau
Journal:  J Gerontol       Date:  1966-10

7.  Social relationships, gender, and allostatic load across two age cohorts.

Authors:  Teresa E Seeman; Burton H Singer; Carol D Ryff; Gayle Dienberg Love; Lené Levy-Storms
Journal:  Psychosom Med       Date:  2002 May-Jun       Impact factor: 4.312

8.  Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study.

Authors:  Hélène Payette; Ronenn Roubenoff; Paul F Jacques; Charles A Dinarello; Peter W F Wilson; Leslie W Abad; Tamara Harris
Journal:  J Am Geriatr Soc       Date:  2003-09       Impact factor: 5.562

9.  Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty.

Authors:  Sean X Leng; Anne R Cappola; Ross E Andersen; Marc R Blackman; Kathleen Koenig; Michael Blair; Jeremy D Walston
Journal:  Aging Clin Exp Res       Date:  2004-04       Impact factor: 3.636

Review 10.  Frailty in the elderly: contributions of sarcopenia and visceral protein depletion.

Authors:  Theodore B Vanitallie
Journal:  Metabolism       Date:  2003-10       Impact factor: 8.694

View more
  57 in total

1.  Allostatic Load and Personality: A 4-Year Longitudinal Study.

Authors:  Yannick Stephan; Angelina R Sutin; Martina Luchetti; Antonio Terracciano
Journal:  Psychosom Med       Date:  2016-04       Impact factor: 4.312

2.  Physiological Dysregulation, Frailty, and Risk of Mortality Among Older Adults.

Authors:  Jennifer C Cornman; Dana A Glei; Noreen Goldman; Maxine Weinstein
Journal:  Res Aging       Date:  2016-02-09

Review 3.  Cognitive Frailty in Older People with Type 2 Diabetes Mellitus: the Central Role of Hypoglycaemia and the Need for Prevention.

Authors:  A H Abdelhafiz; A J Sinclair
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

4.  Cognitive functioning in midlife and old age: combined effects of psychosocial and behavioral factors.

Authors:  Stefan Agrigoroaei; Margie E Lachman
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

5.  Frailty, Implantable Cardioverter Defibrillators, and Mortality: a Systematic Review.

Authors:  Michael Y Chen; Ariela R Orkaby; Michael A Rosenberg; Jane A Driver
Journal:  J Gen Intern Med       Date:  2019-07-01       Impact factor: 5.128

6.  Allostatic Load: Importance, Markers, and Score Determination in Minority and Disparity Populations.

Authors:  Erik J Rodriquez; Edward N Kim; Anne E Sumner; Anna M Nápoles; Eliseo J Pérez-Stable
Journal:  J Urban Health       Date:  2019-03       Impact factor: 3.671

7.  Multisystem dysregulation and bone strength: findings from the study of midlife in the United States.

Authors:  Takahiro Mori; Arun S Karlamangla; Sharon Stein Merkin; Carolyn J Crandall; Neil Binkley; Gail A Greendale; Teresa E Seeman
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

8.  Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Société Française de Gériatrie et de Gérontologie) Workshop--Athens January 20-21, 2012.

Authors:  G Berrut; S Andrieu; I Araujo de Carvalho; J P Baeyens; H Bergman; B Cassim; F Cerreta; M Cesari; H B Cha; L K Chen; A Cherubini; M Y Chou; A J Cruz-Jentoft; L De Decker; P Du; B Forette; F Forette; A Franco; R Guimaraes; L M Guttierrez-Robledo; J Jauregui; V Khavinson; W J Lee; L N Peng; C Perret-Guillaume; M Petrovic; F Retornaz; K Rockwood; L Rodriguez-Manas; C Sieber; G Spatharakis; O Theou; E Topinkova; B Vellas; A Benetos
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

9.  Cross-population validation of statistical distance as a measure of physiological dysregulation during aging.

Authors:  Alan A Cohen; Emmanuel Milot; Qing Li; Véronique Legault; Linda P Fried; Luigi Ferrucci
Journal:  Exp Gerontol       Date:  2014-05-05       Impact factor: 4.032

10.  Promoting functional health in midlife and old age: long-term protective effects of control beliefs, social support, and physical exercise.

Authors:  Margie E Lachman; Stefan Agrigoroaei
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.